Fig. 5From: Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trialsAdverse events comparative risk in patients treated with Ribociclib in Monaleesa2 trialsBack to article page
